Agenzie
Seattle Genetics, Astellas drug rapidly shrinks tumors in bladder cancer study
ASCO Conference Highlights 2019
Read the latest news and research about cancer from the annual conference of the American Society of Clinical Oncology.
ASCO Conference Highlights 2019
Read the latest news and research about cancer from the annual conference of the American Society of Clinical Oncology.
Amgen drug shows high response rate in small lung and colon cancer trial
U.S. records 41 new cases of measles last week
Baby gene experiment 'foolish and dangerous'
Caerphilly girl, 7, saves family from carbon monoxide poisoning
Was Daily Enoxaparin Adequate for Anticoagulation After Colorectal Surgery?
Why the Painless Abdominal Bloating in Middle-Age Man?
Shrewsbury and Telford Hospital chief Simon Wright to leave
Obamacare May Have Aided Fight Vs. Ovarian Cancer
or the study, the investigators analyzed data from the U.S. National Cancer Database. They compared nearly 36,000 women who were diagnosed and treated between 2004 and 2009, with more than 37,000 women diagnosed and treated between 2011 and 2014.
Anthony Joshua: When fat helps win fights
Anthony Joshua: When fat helps win fights
With Chronic Afib, LAAs Get Bigger With More Occluder Leaks
Ready to Automate Your Echo Analysis?
FDA Takes Hard Look at CBD
Everything from oils to gummies to pills, creams and ointments are now for sale at supermarkets and specialty chains. You can even get massages infused with CBD, or cosmetics laced with the drug.
Could Two Drugs Fight Prostate Cancer Earlier?
Two drugs that interfere with cancer's ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved for use against more advanced prostate tumors that don't respond to regular therapy.
Drug Extends Lives of Young Breast Cancer Patients
The drug, called Kisqali (ribociclib), is already approved for treating such patients -- based on earlier results showing it can delay the progression of their cancer.